Lancet Oncol 16 (1): 25-35, 2015.[PUBMED Abstract] Finn RS, Martin M, Rugo HS, et al.: Palbociclib and Letrozole in Advanced Breast Cancer.
N Engl J Med 375 (20): 1925-1936, 2016.[PUBMED Abstract] Hortobagyi GN, Stemmer SM, Burris HA, et al.: Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med 375 (18): 1738-1748, 2016.[PUBMED Abstract] Huober J, Barrios CH, Niikura N, et al.: Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.